Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface

Cancer Research

Volumn 69, Issue 17, 2009, Pages 6799-6806

  Zhao, Qicheng ^a   Guo, Xiuli ^b   Nash, Gerard B ^c   Stone, Philip C ^c   Hilkens, John ^d   Rhodes, Jonathan M ^a   Yu, Lu Gang ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GALECTIN 3; HERMES ANTIGEN; MUCIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD44; CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MEMBRANE; CELL POLARITY; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; GALECTIN 3; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MUCIN-1; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROTEIN BINDING;

EID: 70149097554     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1096     Document Type: Article

References (48)

1. Miles FL, Pruitt FL, van-Golen KL, Cooper CR. Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis 2008;25:305-324
2. Kim YS, Gum JR, Jr., Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj J 1996;13:693-707.
3. Hilkens J, Ligtenberg MJ, Vos HL, Litvinov SV. Cell membrane-associated mucins and their adhesion-modulating property. Trends BiochemSci 1992;17:359-363
4. Bresalier RS, Niv Y, Byrd JC, et al. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 1991;87:1037-1045
5. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 1994;106:353-361 (Pubitemid 24041211)
6. Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 1996;7:565-577 (Pubitemid 26112564)
7. Wesseling J, wan der walk SW, Vos HJ, Sonnenberg A, Hilkens J. Epithelin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995;129:255-265
8. Lloyd KO, Burchell J, Kudryashov V, Yin BW, Taylor-Papadimitriou J. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J Biol Chem 1996;271:33325-33334 (Pubitemid 27010142)
9. Yu LG. The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression. Glycoconj J 2007;24:411-420 (Pubitemid 47512574)
10. Singh R, Campbell BJ, Yu LG, et al. Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44. Glycobiology 2001;11:587-592 (Pubitemid 32677836)
11. Baldus SE, Hanisch FG, Kotlarek GM, et al. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms. Cancer 1998;82:1019-1027
12. Baldus SE, Hanisch FG, Monaca E, et al. Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1. Histol Histopathol 1999;14:1153-1158
13. Baldus SE, Wienand JR, Werner JP, et al. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: a clinicopathologic study of 264 patients. Cancer 2000;88:1536-1543
14. Baldus SE, Zirbes TK, Glossmann J, et al. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer. Oncology 2001;61:147-155 (Pubitemid 32786209)
15. McDermott KM, Crocker PR, Harris A, et al. Overexpression of MUC1 reconfigures the binding properties of tumor cells. Int J Cancer 2001;94:783-791 (Pubitemid 33032824)
16. Rahn JJ, Shen Q, Mah BK, Hugh JC. MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1. J Biol Chem 2004;279:29386-29390 (Pubitemid 38915817)
17. Rahn JJ, Chow JW, Horne GJ, et al. MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1. Clin Exp Metastasis 2005;22:475-483
18. Wei X, Xu H, Kufe D. MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 2005;7:167-178
19. Singh PK, Hollingsworth MA. Cell surface-associated mucins in signal transduction. Trends Cell Biol 2006;16:467-476 (Pubitemid 44293402)
20. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005;5:29-41.
21. Takenaka Y, Fukumori T, Raz A. Galectin-3and metastasis. Glycoconj J 2004;19:543-549
22. Glinsky VV, Glinsky GV, Rittenhouse-Olson K, et al. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 2001;61:4851-4857 (Pubitemid 32691901)
23. Khaldoyanidi SK, Glinsky VV, Sikora L, et al. MDAMB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. J Biol Chem 2003;278:4127-4134 (Pubitemid 36801149)
24. Iurisci I, Tinari N, Natoli C, et al. Concentrations of galectin-3in the sera of normal controls and cancer patients. Clin Cancer Res 2000;6:1389-1393 (Pubitemid 30226225)
25. Saussez S, Lorfevre F, Lequeux T, et al. The determination of the levels of circulating galectin-1 and -3in HNSCC patients could be used to monitor tumour progression and/or responses to therapy. Oral Oncol 2008;44:86-93. (Pubitemid 350251284)
26. Vereecken P, Zouaoui Boudjeltia K, Debray C, et al. High serum galectin-3in advanced melanoma: preliminary results. Clin Exp Dermatol 2006;31:105-109
27. Yu LG, Andrews N, Zhao Q, et al. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem 2007;282:773-781 (Pubitemid 47076627)
28. Sheikh S, Rainger GE, Gale Z, Rahman M, Nash GB. Exposure to fluid shear stress modulates the ability of endothelial cells to recruit neutrophils in response to tumor necrosis factor-α: a basis for local variations in vascular sensitivity to inflammation. Blood 2003;102:2828-2834
29. Leteurtre E, Gouyer V, Rousseau K, et al. Differential mucin expression in colon carcinoma HT-29 clones with variable resistance to 5-fluorouracil and methotrexate. Biol Cell 2004;96:145-151 (Pubitemid 38391197)
30. Schol DJ, Meulenbroek MFA, Snijdewint FGM, et al. 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence. Tumor Biol 1998;19:35-45.
31. Grinstead JS, Koganty RR, Krantz MJ, Longenecker BM, Campbell AP. Effect of glycosylation on MUC1 humoral immune recognition: NMR studies of MUC1 glycopeptide-antibody interactions. Biochemistry 2002;41:9946-9961
32. Draffin JE, McFarlane S, Hill A, et al. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 2004;64:5702-5711 (Pubitemid 39095568)
33. Fujisaki T, Tanaka Y, Fujii K, et al. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res 1999;59:4427-4434 (Pubitemid 29418764)
34. Ligtenberg MJ, Vos HL, Gennissen AM, Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J Biol Chem 1990;265:5573-5578 (Pubitemid 20127185)
35. Krause T, Turner GA. Are selectins involved in metastasis? Clin Exp Metastasis 1999;17:181-192
36. Zhang K, Baeckström D, Brevinge H, Hansson GC. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J Cell Biochem 1996;60:538-549 (Pubitemid 26112066)
37. Lowe JB. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr Opin Cell Biol 2003;15:531-538 (Pubitemid 37176961)
38. Li YS, Kaneko M, Sakamoto DG, Takeshima Y, Inai K. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast. Breast Cancer 2006;13:58-63.
39. Kurtenkov O, Klaamas K, Mensdorff-Pouilly S, Miljukhina L, Shljapnikova L, Chuzmarov V. Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival. Acta Oncol 2007;46:316-323 (Pubitemid 46625032)
40. Baldus SE, Wienand JR, Werner JP, et al. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope. Int J Oncol 2005;27:1289-1297
41. Heimburg J, Yan J, Morey S, et al. Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia 2006;8:939-948 (Pubitemid 44706244)
42. Kim YJ, Varki A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J 1997;14:569-576 (Pubitemid 27353200)
43. Gorelik E, Galili U, Raz A. On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev 2001;20:245-277 (Pubitemid 34595270)
44. Albini A, Mirisola V, Pfeffer U. Metastasis signatures: genes regulating tumor-microenvironment interactions predict metastatic behavior. Cancer Metastasis Rev 2008;27:75-83.
45. Finak G, Bertos N, Pepin F, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008;14:518-527 (Pubitemid 351655218)
46. Bresalier RS, Mazurek N, Sternberg LR, et al. Metastasis of human colon cancer is altered by modifying expression of the β-galactoside-binding protein galectin 3. Gastroenterology 1998;115:287-296 (Pubitemid 28363421)
47. Mourad-Zeidan AA, Melnikova VO, Wang H, Raz A, Bar-Eli M. Expression profiling of galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry. Am J Pathol 2008;173:1839-1852
48. Honjo Y, Nangia-Makker P, Inohara H, Raz A. Downregulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 2001;7:661-668 (Pubitemid 32707992)